Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0724-2026

Xpert MTB/RIF. Recall

Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Xpert MTB/RIF.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0724-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 5, 2025
FDA report date
Dec 3, 2025
Quantity in commerce
9,880 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Xpert MTB/RIF. Model Number: GXMTB/RIF-US-10.

Affected model & UDI checker

Search the exact identifiers published for Z-0724-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
GXMTB/RIF-US-10Xpert MTB/RIF.Check source noticeNot specified
Not specifiedXpert MTB/RIF.Check source notice07332940000912
FDA code information

Model Number: GXMTB/RIF-US-10. UDI-DI: 07332940000912. Batch: 1000812229. Lot: 41302. Expiration Date: 2025-02-02

View the original FDA recall notice

Why was this product recalled?

Product testing did not meet expected stability criteria.

What actions did Cepheid take?

Cephid notified consignees on about 11/05/2025 via FedEx letter. Consignees were instructed to ensure no affected units remain in inventory or are available for use since the affected lots have passed their expiration date. Past results obtained from Xpert MTB/RIF batch 1000812229 lot 41302 may be inaccurate. If these results were used to make clinical management decisions, it is recommended that the results be reviewed in the context of corresponding culture data, drug susceptibility testing, clinical presentation and other relevant laboratory information to ensure accurate patient care. If there is uncertainty or insufficient information to confirm the result, repeat testing to ensure accuracy. Consignees were requested to notify relevant clinical teams as needed. Cepheid will provide products for the purposes of retesting. Kits are expected to ship within 5 business days following receipt of the completed response form. Additionally, consignees were instructed to complete and return the Customer Response Form.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology